Schonfeld Strategic Advisors LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2022$73,000
+102.8%
42,441
+196.5%
0.00%
Q4 2020$36,000
-77.9%
14,313
-77.9%
0.00%
-100.0%
Q3 2020$163,000
-73.5%
64,621
-65.7%
0.00%
-62.5%
Q2 2020$616,000
+962.1%
188,188
+1620.0%
0.01%0.0%
Q4 2016$58,00010,9410.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders